GPC3 and hepatocellular carcinoma: GPC3 CAR T cells were found to eliminate GPC3-positive HCC cells in mouse models [54], and a phase I clinical trial demonstrated its safety, as well as some early signs of anti-tumor activity of GPC3 CAR T cells in patients with advanced HCC [55].